|
|
|
|
A unit investment trust that seeks above-average capital appreciation by investing in a portfolio of small- and mid-capitalization companies which have strong balance sheets.
Please note that there is no assurance the objective will be met.
|
|
|
Product Code: |
SMCO31 |
Portfolio Status: |
Primary |
Initial Offer Date: |
09/11/2024 |
Portfolio Ending Date: |
12/11/2025 |
Tax Structure: |
Regulated Investment Company |
Distributions: |
Semi-Annual |
|
|
|
Initial Offer Price: |
$10.0000 |
NAV(*): |
$10.7496 |
POP(*): |
$10.9013 |
Remaining Deferred Sales Charge: |
$0.1350 |
|
* As of Trade Date: 11/20/2024 4:00pm ET
|
|
The Public Offering Price (POP) represents the net asset value per unit plus any applicable organization costs and sales charges.
The Net Asset Value (NAV) represents the value per unit of a trust’s portfolio securities and other assets reduced by applicable deferred sales charges and other liabilities.
Historical 12-Month Distribution of Trust Holdings:^ |
|
|
|
^ There is no guarantee the issuers of the securities included in the trust will declare dividends or distributions in the future. The historical 12-month
distribution per unit and historical 12-month distribution rate of the securities included in the trust are for illustrative purposes only and are not indicative
of the trust's distribution or distribution rate. The historical 12-month
distribution per unit is based on the weighted average of the trailing twelve month distributions paid by the securities included in the portfolio. The historical
12-month distribution rate is calculated by dividing the historical 12-month distributions by the trust's offering price. The historical 12-month distribution and
rate are reduced to account for the effects of fees and expenses, which will be incurred when investing in a trust.
Certain of the issuers may have reduced their dividends or distributions over the prior twelve months. The distribution per unit and rate paid by the trust may be
higher or lower than the amount shown above due to certain factors that may include, but are not limited to, a change in the dividends or distributions paid by
issuers, actual expenses incurred, or the sale of securities in the portfolio. For trusts that include funds, distributions may include realized short term
capital gains, realized long-term capital gains and/or return of capital.
|
Communication Services |
0.00% |
Consumer Discretionary |
16.70% |
Consumer Staples |
7.37% |
Energy |
5.33% |
Financials |
14.36% |
Health Care |
15.67% |
Industrials |
24.20% |
Information Technology |
13.87% |
Materials |
2.39% |
Real Estate |
0.00% |
Utilities |
0.00% |
Other |
0.11% |
|
|
|
Large |
Mid |
Small |
|
Growth |
0.00% |
52.57% |
34.87% |
|
Value |
0.00% |
12.45% |
0.00% |
|
Large-Cap Growth |
0.00% |
Large-Cap Value |
0.00% |
Mid-Cap Growth |
52.57% |
Mid-Cap Value |
12.45% |
Small-Cap Growth |
34.87% |
Small-Cap Value |
0.00% |
Undetermined |
0.11% |
|
U.S. Stocks |
94.41% |
|
Other |
0.11% |
Non-U.S. Stocks |
5.48% |
|
|
|
|
|
The style and sector characteristics of the portfolio are determined as of 11/19/2024
and will likely vary thereafter due to market fluctuations in the underlying securities. |
Weighted Average Market Cap |
$9,672 |
Price/Earnings |
19.00 |
Price/Book |
4.23 |
|
As of 11/19/2024
|
|
All market capitalization numbers are in USD$ Millions. All figures are subject to change.
Corcept Therapeutics Incorporated
| CORT |
Health Care
| Small-Cap Growth |
3.47%
|
Comfort Systems USA, Inc.
| FIX |
Industrials
| Mid-Cap Growth |
3.43%
|
Interactive Brokers Group, Inc. (Class A)
| IBKR |
Financials
| Mid-Cap Growth |
3.40%
|
InterDigital, Inc.
| IDCC |
Information Technology
| Small-Cap Growth |
3.15%
|
EMCOR Group, Inc.
| EME |
Industrials
| Mid-Cap Growth |
3.14%
|
Mueller Industries, Inc.
| MLI |
Industrials
| Mid-Cap Growth |
3.02%
|
Applied Industrial Technologies, Inc.
| AIT |
Industrials
| Mid-Cap Growth |
2.96%
|
East West Bancorp, Inc.
| EWBC |
Financials
| Mid-Cap Value |
2.95%
|
Stride, Inc.
| LRN |
Consumer Discretionary
| Small-Cap Growth |
2.94%
|
Axos Financial, Inc.
| AX |
Financials
| Small-Cap Growth |
2.87%
|
Evercore Inc.
| EVR |
Financials
| Mid-Cap Growth |
2.84%
|
Fabrinet
| FN |
Information Technology
| Mid-Cap Growth |
2.76%
|
nVent Electric Plc
| NVT |
Industrials
| Mid-Cap Growth |
2.72%
|
Texas Roadhouse, Inc.
| TXRH |
Consumer Discretionary
| Mid-Cap Growth |
2.69%
|
Cactus, Inc. (Class A)
| WHD |
Energy
| Small-Cap Growth |
2.68%
|
Magnolia Oil & Gas Corporation (Class A)
| MGY |
Energy
| Small-Cap Growth |
2.65%
|
ITT Inc.
| ITT |
Industrials
| Mid-Cap Growth |
2.63%
|
Casey's General Stores, Inc.
| CASY |
Consumer Staples
| Mid-Cap Growth |
2.51%
|
e.l.f. Beauty, Inc.
| ELF |
Consumer Staples
| Mid-Cap Growth |
2.50%
|
Abercrombie & Fitch Co. (Class A)
| ANF |
Consumer Discretionary
| Mid-Cap Growth |
2.45%
|
Toll Brothers, Inc.
| TOL |
Consumer Discretionary
| Mid-Cap Value |
2.44%
|
United Therapeutics Corporation
| UTHR |
Health Care
| Mid-Cap Value |
2.40%
|
Cabot Corporation
| CBT |
Materials
| Mid-Cap Growth |
2.39%
|
Ingredion Incorporated
| INGR |
Consumer Staples
| Mid-Cap Value |
2.36%
|
American Financial Group, Inc.
| AFG |
Financials
| Mid-Cap Value |
2.30%
|
Installed Building Products, Inc.
| IBP |
Consumer Discretionary
| Small-Cap Growth |
2.30%
|
Crane NXT, Co.
| CXT |
Information Technology
| Small-Cap Growth |
2.29%
|
Simpson Manufacturing Co., Inc.
| SSD |
Industrials
| Mid-Cap Growth |
2.28%
|
AppFolio, Inc. (Class A)
| APPF |
Information Technology
| Mid-Cap Growth |
2.28%
|
Neurocrine Biosciences, Inc.
| NBIX |
Health Care
| Mid-Cap Growth |
2.25%
|
TopBuild Corp.
| BLD |
Consumer Discretionary
| Mid-Cap Growth |
2.14%
|
Medpace Holdings, Inc.
| MEDP |
Health Care
| Mid-Cap Growth |
2.10%
|
Advanced Drainage Systems, Inc.
| WMS |
Industrials
| Mid-Cap Growth |
2.08%
|
Harmony Biosciences Holdings, Inc.
| HRMY |
Health Care
| Small-Cap Growth |
1.95%
|
Verra Mobility Corporation
| VRRM |
Industrials
| Small-Cap Growth |
1.94%
|
Lantheus Holdings, Inc.
| LNTH |
Health Care
| Small-Cap Growth |
1.81%
|
Crocs, Inc.
| CROX |
Consumer Discretionary
| Small-Cap Growth |
1.74%
|
Cirrus Logic, Inc.
| CRUS |
Information Technology
| Small-Cap Growth |
1.73%
|
Halozyme Therapeutics, Inc.
| HALO |
Health Care
| Small-Cap Growth |
1.69%
|
Insight Enterprises, Inc.
| NSIT |
Information Technology
| Small-Cap Growth |
1.66%
|
|
|
Total Number of Holdings: 40 |
|
Underlying Securities information represented above is as of 11/19/2024 but will vary with future fluctuations in the market. |
Standard Account Sales Charges * |
Transactional sales charges: |
Initial: |
0.15% |
|
Deferred: |
1.24% |
C&D Fee: |
|
0.46% |
Maximum Sales Charge: |
|
1.85% |
|
30337K106 |
Cash |
Semi-Annual |
30337K114 |
Reinvest |
Semi-Annual |
|
* Based on the offer price as of 11/20/2024 4:00pm ET |
Fee/Wrap Account Sales Charges * |
C&D Fee: |
|
0.47% |
Maximum Sales Charge: |
|
0.47% |
|
30337K122 |
Cash-Fee |
Semi-Annual |
30337K130 |
Reinvest-Fee |
Semi-Annual |
|
* Based on the NAV price as of 11/20/2024 4:00pm ET |
In addition to the sales charges listed, UITs for both brokerage and advisory accounts are subject to annual operating expenses and organization costs. See the prospectus for additional information.
Deferred Sales Charge Schedule |
$0.04500
|
December 20, 2024
|
$0.04500
|
January 17, 2025
|
$0.04500
|
February 20, 2025
|
|
Risk Considerations Equity Risk. An investment in a portfolio containing common stocks is subject to certain risks, such as an economic recession and the possible deterioration of either the financial condition of the issuers of the equity securities or the general condition of the stock market. Buy & Hold Risk – Taxable Trusts. This UIT is a buy and hold strategy and investors should consider their ability to hold the trust until maturity. There may be tax consequences unless units are purchased in an IRA or other qualified plan. COVID-19 Economic Impact Risk. The ongoing effects of the COVID-19 global pandemic, or the potential impacts of any future public health crisis, may cause significant volatility and uncertainty in global financial markets. While vaccines have been developed, there is no guarantee that vaccines will be effective against future variants of the disease. Foreign Securities Risk. Securities of non-U.S. issuers are subject to additional risks, including currency fluctuations, political risks, withholding, the lack of adequate financial information, and exchange control restrictions impacting non-U.S. issuers. Market Disruption Risk. Ongoing armed conflicts between Russia and Ukraine in Europe and among Israel, Hamas and other militant groups in the Middle East, have caused and could continue to cause significant market disruptions and volatility within the markets in Russia, Europe, the Middle East and the United States. The hostilities and sanctions resulting from those hostilities could have a significant impact on certain investments as well as performance. Small-Cap and Mid-Cap Risk. An investment in a portfolio containing small-cap and mid-cap companies is subject to additional risks, as the share prices of small-cap companies and certain mid-cap companies are often more volatile than those of larger companies due to several factors, including limited trading volumes, products, financial resources, management inexperience and less publicly available information. Volatility Risk. The value of the securities held by the trust may be subject to steep declines or increased volatility due to changes in performance or perception of the issuers. Operational Risk. As the use of Internet technology has become more prevalent in the course of business, the trust has become more susceptible to potential operational risks through breaches in cybersecurity.
The style and capitalization characteristics used to describe the stocks are designed to help you
understand how they fit into your overall investment plan. Due to changes in the value of the stocks
the characteristics may vary over time. In general, growth stocks have high relative price-to-book
ratios while value stocks have low relative price-to-book ratios. In determining market capitalization
characteristics, we analyze the market capitalizations of the 3,000 largest stocks in the U.S. (excluding
foreign securities, ADRs, limited partnerships and regulated investment companies) on a monthly basis.
Companies with market capitalizations among the largest 10% are considered Large-Cap securities, the next
20% are considered Mid-Cap securities and the remaining securities are considered Small-Cap securities.
You should carefully consider the trust's investment objectives, risks, and charges and expenses before investing. Contact your financial professional or call First Trust Portfolios, L.P. at 1.800.621.1675 to request a prospectus, which contains this and other information about the trust. Read it carefully before you invest.
This product information does not constitute an offer to sell, or a solicitation of an offer to buy securities in any state to any person to whom it is not lawful to make such an offer. Sales of any of these securities must include prospectus delivery and the services of a retail broker/dealer duly licensed in the appropriate states.
Not FDIC Insured, Not Bank Guaranteed and May Lose Value.
CUSIP identifiers have been provided by CUSIP Global Services, managed on behalf of the American Bankers Association by FactSet Research Systems Inc. and are not for use or dissemination in a manner that would serve as a substitute for any CUSIP service. The CUSIP Database, ©2024 CUSIP Global Services. "CUSIP" is a registered trademark of the American Bankers Association.
|
|
30337K106 |
(Cash) |
30337K114 |
(Reinvest) |
30337K122 |
(Cash-Fee) |
30337K130 |
(Reinvest-Fee) |
|
|
|
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|